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Summary
Bovine viral diarrhea virus (BVDV) is a pestivirus that affects both cattle and sheep, 
causing an array of clinical signs, which include abortions and malformations in the 
offspring. Manufacturing of modified live virus (MLV) vaccines often includes the use of 
bovine-derived products, which implies a risk of contamination with viable BVDV. 
Recently, the circulation of a specific strain of BVDV 2b among Spanish sheep flocks, 
associated with outbreaks of abortions and malformations, and whose origin was not 
determined, has been observed. On February 2018 a MLV orf vaccine was applied to a 
1600 highly prolific sheep flock in the Northeast of Spain that included 550 pregnant 
ewes. In May 2018, during the lambing season, an unusual high rate (72.7%) of 
abortions, stillbirths, congenital malformations and neurological signs in the offspring was 
observed. It was estimated that about 1000 lambs were lost. Three 1- to -3-day-old 
affected lambs and a sealed vial of the applied vaccine were studied. Lambs showed 
variable degrees of central nervous system malformations and presence of pestiviral 
antigen in the brain. Molecular studies demonstrated the presence of exactly the same 
BVDV 2b in the tissues of the three lambs and in the orf vaccine, thus pointing to a 
pestivirus contamination in the applied vaccine as the cause of the outbreak. 
Interestingly, sequencing at the 5’-untranslated region-(UTR) of the contaminating virus 
showed a complete match with the virus described in the previously-reported outbreaks 
in Spain, thus indicating that the same contaminated vaccine could have also played a 
role in those cases. This communication provides a clear example of the effects of the 
application of this contaminated product in a sheep flock. The information presented here 
can be of interest in putative future cases of suspected circulation of this or other BVDV 
strains in ruminants.
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1. Introduction
Bovine viral diarrhea virus species 1 and 2 (BVDV 1 and BVDV 2, or Pestivirus A 
and Pestivirus B, respectively) are single stranded RNA viruses that belong to the genus 
Pestivirus, family Flaviviridae. They infect mainly cattle, although natural and 
experimental interspecies transmission to pigs, sheep, and other domestic and wild 
ruminants have been described (Tao et al., 2013; Hill, Reichel, & Brownlie, 2014; 
Simmonds et al., 2017; Hopkins, Mitchell, Carson, Russell, & Hateley, 2019; Lanyon; 
Ricci, Bartolini, Morandi, Cuteri, & Preziuso, 2019).
BVDV causes bovine viral diarrhea (BVD) and mucosal disease, which encompass 
a series of gastrointestinal and hemorrhagic disorders, immunosuppression, and 
reproductive problems. Indeed, in utero infection of the bovine fetus induces embryonic 
resorptions, stillbirths, and teratogenic effects, which result in central nervous system 
(CNS) malformations. Furthermore, infected pregnant females may give birth to 
immunotolerant persistently infected (PI) individuals, which are a permanent source of 
BVDV (Lanyon et al., 2014; Evans et al., 2019). Similar syndromes in sheep naturally or 
experimentally infected with BVDV 1 or BVDV 2 have been described (Scherer et al., 
2001; Hopkins et al., 2019). In Spain, most of the reported bovine isolates belong to 
BVDV 1, with three sporadic descriptions of BVDV 2 (Diéguez, Cerviño, & Yus, 2017). 
Interestingly, the same strain of BVDV 2b has been recently isolated in several Spanish 
sheep farms associated with outbreaks of a border disease-like syndrome that included 
abortions and malformations in the offspring (Elvira Partida et al., 2017). 
Modified live virus (MLV) vaccines are sometimes manufactured using bovine-
derived products, such as fetal bovine serum, which is a frequent component of the 
culture mediums (Makoschey, van Gelder, Keijsers, & Goovaerts, 2003; Kozasa et al., 
2011; Monteiro et al., 2018). This serum may contain viable BVDV if obtained from a PI 
fetus (Bolin, Matthews, & Ridpath, 1991; Erickson, Bolin, & Landgraf, 1991), which 
implies a risk of contamination of the finished vaccine and related disease when applied 
to susceptible species, especially to pregnant females (Wensvoort & Terpstra, 1988; 










This article is protected by copyright. All rights reserved
The use of BVDV-contaminated vaccines may also induce unapparent PI 
individuals that promote circulation of previously unreported BVDV strains in a given 
geographical area. Thus, it is important to report these cases and the characteristics of 
the contaminating viral agent to determine whether outbreaks of new BVDV strains have 
a spontaneous or an iatrogenic origin. In this report, we describe a case of abortions and 
malformations in lambs associated with a MLV orf vaccine contaminated with a strain of 
BVDV 2b.
2. Materials and methods
2.1. Case history
The case occurred in a 1600, highly prolific (>2 lambs/ewe and lambing season), 
meat-focused, Lacaune sheep flock, located in the Northeast of Spain. Five-hundred-
and-fifty ewes were mated on December 2017. The flock had reported recurrent 
outbreaks of orf in lambs and ewes in the past, thus all the animals, including the 550 
pregnant ewes, were vaccinated subcutaneously with 0.5 mL of a MLV orf vaccine 
(Overvac EC, Laboratorios Ovejero, Spain; batch No. 141J002A) on February 18th, 2018.
On April 12th, 2018 a rapid alert was released by the Spanish Agency of Medicines 
and Medical Devices (AEMPS) warning about a likely contamination of this product with 
pestivirus and asking for a preventative withdrawal from the market (AEMPS, 2018a; 
AEMPS, 2018b). During the pregnancy, and especially at the beginning of the lambing 
season (May 2018), the farmer reported an unusual high rate of reproductive failure 
(400/550; 72.7%) that included abortions, resorptions, and/or stillbirths, and clinical signs 
such as tremors, ataxia, and prostration in the lambs that were born alive (Supplementary 
Video S1). The farmer estimated that more than 1000 lambs were lost, either directly or 
by humane euthanasia.
An abortion diagnostic panel was carried out. Microbiological cultures from vaginal 
swabs and placentas of 8 aborted sheep were performed using non-selective and 
selective media for Salmonella spp., Campylobacter spp., and Brucella spp. and smears 
from these samples were studied by Stamp staining for Chlamydia (C.) abortus and 
Coxiella (C.) burnetti inclusions visualization. PCR with primers for C. abortus, C. 
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samples of the 8 animals. Finally, sera from maternal blood of 2 of these aborted sheep 
were analyzed by ELISA to detect antibodies against C. abortus, C. burnetti, N. caninum, 
and pestivirus. On June 7th, 2018, three 1- to 3-day-old lambs (Nos. 1-3) and a sealed 
vial of the vaccine were submitted for further testing.
2.2. Macroscopic examination, histopathology, and immunohistochemistry
Necropsies of the three lambs were carried out and tissue samples from different 
organs were fixed in 10% neutral-buffered formalin for 48h and processed routinely for 
staining with hematoxylin and eosin (HE) and luxol fast blue (only in CNS). Formalin-
fixed, paraffin-embedded tissue sections from brain, thyroid gland, lung, oral mucosa, 
and aural skin were submitted to immunohistochemistry (IHC) for pestiviral antigen 
detection. The panpestiviral 15c5 antibody (dilution 1:10000; E. Dubovi, Cornell 
University, USA) targeting the glycoprotein gp48 (Erns) was used as described (Hilbe et 
al., 2007).
2.3. Molecular analyses in tissues
Ultra-frozen (-80°C) tissue samples from the same organs chosen for IHC were 
used for viral nucleic acid detection of ruminant pestiviruses as described and performed 
in our Swiss reference laboratory for ruminant pestiviruses (Braun et al., 2018). Briefly, 
tissue samples were divided into small pieces, and homogenized using the QIAshredder 
from the QIAamp RNeasy blood mini Kit (Qiagen, Hombrechtikon, Switzerland) for 
isolation of total RNA. Quantitative reverse transcription PCR (RT-qPCR) was performed 
with probes for BVDV 1 and BVDV 2 using the QuantiTect Probe One Step RT-PCR Kit 
(Qiagen). Reactions were run with primers in the 5’-untranslated region (-UTR), and the 
amount of viral RNA in the samples was expressed in cycle threshold (Ct) values. A Ct 
value of ≤ 32 was considered as positive, a value of >32 up to <45 as weakly positive, 
and a value of ≥45 as negative. For positive and weakly positive samples, a classic RT-
PCR was done, again with primers targeting the 5’-UTR. In all cases where a band in the 
agarose gel was obtained, the fragment was sequenced by Sanger method and the data 
analyzed as described (Stalder et al., 2016). In addition, for selected samples, a fragment 
in the NS3/4A region (1149 nt) was sequenced by the Sanger method for further 
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2.4. Molecular analyses in the vaccine
The vaccine was reconstituted in 5 mL of the provided solvent as indicated by the 
manufacturer. The reconstituted product was homogenized and three aliquots of 200 µL 
were used for pestiviral RNA detection and 5’-UTR sequencing as described for the 
tissues. Virus isolation and propagation studies were done on primary bovine turbinate 
(BT) cells prepared in house and on the MDBK cell line. These cells and the serum used 
to propagate them were free of BVDV and antibodies against BVDV (Lussi, Sauter, & 
Schweizer, 2018). Two subsequent cellular passages were done. For the first one, 
300 µL of the reconstituted vaccine suspension was added to the cells in a test tube 
together with 2 mL of medium, and incubated at 37°C in a humidified 5% CO2-
atmosphere for 5 days. For the second passage, 300 µL of the supernatant was added to 
fresh cells with 2 mL of fresh medium. Supernatants of both passages were analyzed for 
the presence of pestiviral RNA and antigen. For antigen detection, 50 µL of both cell 
culture supernatants together with 100 µL fresh medium were added per well to the 
corresponding cell types in 96-well plates (in duplicates), incubated for 4-5 days prior to 
fixation, and stained with immunoperoxidase (IPO) using a polyclonal swine-α-BVDV 
hyperimmune serum as primary antibody prepared at the Institute of Veterinary Virology, 
University of Bern (Kaiser, Nebel, Schupbach-Regula, Zanoni, & Schweizer, 2017). For 
pestiviral RNA detection, 200 µL of the supernatant of each passage were used for RNA 
isolation using the NucleoMag® VET Viral RNA/DNA isolation kit (Macherey-Nagel 
GmbH, Oensingen, Switzerland) on the Thermo Scientific KingFisher Flex purification 
systemTM followed by RT-qPCR and 5’-UTR or NS3/4A sequencing as described for the 
tissues.
3. Results and discussion
A severe outbreak of embryonic loss, abortions, stillbirths, and congenital CNS 
malformations occurred in a Lacaune sheep flock and prompted to research on its 
etiology. As a first approach, an abortion diagnostic panel on placentas, fetal organs, and 
maternal blood was carried out. All microbiological cultures tested negative, and neither 
C. abortus nor C. burnetti inclusions were observed in the smears. PCR from fetal organs 
and placentas were positive for pestivirus, only. ELISA tests on maternal blood showed 
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and pestivirus (2/2). However, serology of individually aborted animals is of little value as 
the presence of serum antibodies indicates contact rather than infection, and may also be 
influenced by vaccination (i.e. in the case of C. abortus) (Holler, 2012). Furthermore, no 
nucleic acids from C. abortus, C. burnetti, or N. caninum were detected in the fetal 
organs/placental tissues, thus the panel pointed to pestivirus as the most likely 
contributor to the clinicopathologic picture observed. On top of that, the Spanish 
authorities had already warned about the possibility of pestivirus contamination in the 
applied vaccine (AEMPS, 2018a; AEMPS, 2018b), and therefore further studies were 
performed to explore that possibility. 
The three lambs presented different degrees of similar changes in the CNS (Figure 
1; Supplementary Figures S1-2). Grossly, hydrocephalus (lamb No. 2), severe 
hydranencephaly with almost no remaining cortical parenchyma in the rostral areas and 
meningeal collapse (lambs Nos. 1 and 3), together with markedly reduced cerebellar 
sizes (lambs Nos. 2 and 3) were observed. Histologically, the three animals presented 
variable combinations of atrophy and dysgenesis in the cortex. Cerebellar sections 
demonstrated irregular and poorly-developed folia (Figure 2a). There were rarefaction, 
spongiosis, and hypomyelination in the white matter, and rare meningeal infiltrates of 
mononuclear inflammatory cells. Those lesions suggested in utero pestiviral infection, 
and the lesion variability among the three animals pointed to infection of fetal CNS during 
different times of prenatal development, since tissue susceptibility varies according to 
fetal age (Cantile, 2016). 
Pestiviral antigen was detected at least in one tissue per animal by IHC. Brain 
(neurons and endothelial cells) showed the most consistent results across the three 
lambs, with positive signal obtained in lamb No. 1, and mildly positive signals in lambs 
Nos. 2 and 3 (Figure 2b; Supplementary Figures S3-4). Indeed, the degree and location 
of pestiviral antigen detection in brain tissue vary according to the moment of pregnancy 
and the extent and severity of microscopic lesions (Hewicker-Trauwein & Trautwein, 
1994). Furthermore, the following tissues were also positive: thyroid gland (endothelial 
cells, fibrocytes, and follicular epithelial cells; lambs Nos. 1 and 2), lung (endothelial cells; 
lamb No. 1), oral mucosa (epithelial and endothelial cells; lambs Nos. 1 and 3), and aural 
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RT-qPCR for ruminant pestiviruses was positive or weakly positive with the BVDV 
2 probe in various samples from all three animals (Table 1). The 5’-UTR could be 
sequenced at least in one tissue per animal and confirmed the presence of an identical 
nucleotide sequence belonging to the same species of BVDV 2b. Interestingly, positive 
results and successful sequencing were obtained in brain samples from the three 
animals, which along with the lesions described and the successful antigen detection 
pointed towards the selective neurotropism of this BVDV 2b strain in sheep and to an 
active BVDV 2 infection in the three lambs.
To investigate whether pestiviral RNA and infectious pestiviruses were present in 
the orf vaccine, a fresh, sealed vial of the product was analyzed by RT-qPCR and virus 
isolation. A first RT-qPCR in the 5’-UTR, run directly from an aliquot of the reconstituted 
vaccine, yielded a negative result. To confirm this result, the direct RT-qPCR analysis of 
the reconstituted vaccine was repeated. Two new, fresh 200 µL aliquots from the vaccine 
suspension were prepared and the RT-qPCR was run in duplicate. This time, both 
samples yielded weakly positive results for the BVDV 2 probe, with Ct values of 36.9 and 
37.4, respectively. Re-amplification of the newly isolated RNA generated an amount of 
product that was sufficient for subsequent sequencing. These sequences yielded a 
complete match to the ones obtained in tissues from the three animals. Subsequently, 
the presence of infectious virus was evaluated by viral propagation in two cell lines (i.e., 
BT and MDBK). Analysis by IPO staining of both passages showed positive result for 
pestivirus antigen. Controls in the absence of added vaccine samples remained negative 
in all the passages. RT-qPCR analyses yielded positive results for BVDV 2, with Ct 
values around 21 and 20 for BT cells, and 29 and 20 for MDBK cells in passages 1 and 
2, respectively. All internal positive and negative controls showed the expected results. 
Sequencing in the 5’-UTR of both passages on either cell type yielded positive results, 
with all four samples displaying identical nucleotide sequences belonging to BVDV 2b 
species. Furthermore, this nucleotide sequence was again the same as in the tissues of 
the three lambs studied and as found in the reconstituted vaccine. To further confirm the 
identity of the viruses in the vaccine and in the fetuses, we further sequenced a fragment 
of 1149 nt in length in the NS3/NS4A region of the viral genome in the brain of lambs 1 
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cells. Again, all the sequences were identical in these four samples (GenBank No. 
MT113951), with the exception of one to three synonymous changes with the base A 
instead of G at position 919 in the two cell culture supernatants and in the brain of lamb 
2, and two ambiguities in the sample of the brain of lamb 2 (A or T instead of an A at 
position 1008, and an A or G instead of an A at position 1092).
Therefore, BVDV 2b was found in the vaccine vial but, based on the RT-qPCR 
results in the 5’-UTR, most likely at a rather low level. In consequence, by taking a 
random aliquot of the reconstituted vaccine, not every sample might contain viral RNA at 
a sufficient amount to be detected by RT-qPCR, explaining the variable results observed. 
By contrast, a small number of infectious virus might be sufficient to infect and propagate 
in cell cultures. Thus, based on successful virus isolation on two different types of cell 
lines, the vaccine contained viable (i.e. infectious) virus that was able to propagate once 
it was on cell culture and, most likely, when injected into a live animal. Indeed, the 
nucleotide sequences in the tissues of the lambs was the same as that in the vaccine, 
thus pointing to such a vaccine as the sole source of infection and the cause of the 
massive outbreak that occurred in the flock.
The severity and explosiveness of the outbreak studied may be related to the 
moment of pregnancy in which the vaccine was applied. Some protocols of ovine 
immunization recommend applying orf vaccines during pregnancy in order to guarantee 
passive transfer of antibodies to neonatal lambs through the colostrum (Lacasta et al., 
2015). It is a common practice among farmers to have their ewes vaccinated around the 
last month of pregnancy (120-150 days), when the susceptibility of the developing fetus 
to pestiviral infection is lowest (Nettleton & Entrican, 1995; Schweizer & Peterhans, 
2014). Actually, vaccination (i.e. BVDV 2 inoculation) at that moment would probably 
have produced apparently healthy animals and a low rate of abortions and 
malformations. Due to flock management practices in the present case, vaccination was 
carried out earlier, around the second month (60 days) of pregnancy, when the 
susceptibility of the fetus to pestiviral infection is highest.
The observed reproductive failure rate resembles that of an experimental BVDV 2 
infection carried out in pregnant ewes (Scherer et al., 2001), in which animals were 
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and 66.6%, respectively. A third group of ewes was inoculated at 120-125 days, which 
gave birth to seropositive, virus-negative, healthy lambs. Similarly, another orf vaccine 
contaminated with pestiviruses, also applied in early pregnancy, led to reproductive 
failure in 82% of the pregnant goats (Løken, Krogsrud, & Bjerkås, 1991). Moreover, in 
this last description, virus was also transmitted from PI goats to sheep and cattle, thus 
demonstrating that further damages in addition to the direct losses in the vaccinated 
animals may occur.
A BLAST search provided two identical 5’-UTR sequences as the one described 
herein: One from a strain in Portugal in 2006 (GenBank No. AY944277) and another from 
Spain in 2015 (GenBank No. KX369602). In the first case, the strain was found in cattle 
affected by hemorrhagic disease (Barros, Ramos, Pauperio, Thompson, & Fevereiro, 
2006). In the Spanish case, it was found in four different sheep flocks located in the 
Northwest and center of the country and that showed severe outbreaks of abortions and 
malformations, in which the origin of the infection could not be established (Elvira Partida 
et al., 2017). The complete nucleotide match in the 5’-UTR and the geographical 
similarities between those ovine outbreaks and the one described in this communication 
suggest that they may have had a similar origin, either by direct application of the 
contaminated vaccine or by introduction of PI animals originated in flocks where the 
vaccine was used. However, as no sequences outside of the 5’-UTR were reported for 
these strains, a more detailed comparison including the sequences in the NS3/4A region 
of the viral genome reported here is not possible. Eiras et al. (2017) described another 
outbreak of abortions in the Northwest of Spain associated with a BVDV 2d strain in 
sheep. The origin of the infection was not determined but the authors suggested that the 
introduction of 4 new rams, one of them being seropositive to pestivirus, could have 
played a role. 
In any case, it seems that the contaminated orf vaccine could be contributing to 
the circulation of BVDV 2b among Spanish sheep flocks, especially in those where the 
vaccine was applied later in pregnancy, in which the clinical signs could remain unnoticed 
for the farmer at short term. However, long term issues associated with the presence of 
PI animals and viral circulation might occur in those flocks in the future, and the origin of 
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related disease in sheep have already been described in other countries (Decaro et al., 
2017; Giangaspero & Harasawa, 2004). Actually, in a survey performed in Italy, BVDV 2c 
was more common among small ruminants than in cattle (Decaro et al., 2017).
Eventually, on 23rd July, 2018, the AEMPS released a new communication 
(AEMPS, 2018c), which confirmed the contamination and called for a definitive 
withdrawal of the product from the market. However, they did not provide either the 
characteristics of the contaminating pestivirus or details about the different outcomes of 
the vaccine application in the affected sheep flocks. This communication describes the 
clinicopathologic presentation in a flock vaccinated with that contaminated product, and 
provides the 5’-UTR and NS3/4A nucleotide sequences of the contaminating virus, which 
will be useful in order to determine the origin of BVDV 2b circulation in similar outbreaks 
in the future.
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Figure legends
Figure 1. Brain, Lamb No. 2. Occipital and parietal lobes show thinning of the cortex, loss 
of cerebral circumvolutions, and hydrocephalus. Cerebellum is markedly reduced in size 
and cerebellar gyri show disorganization. Bar = 1 cm. 
Figure 2. Histological findings and pestiviral antigen detection in the central nervous 
system of lambs infected by BVDV 2b. Fig 2A. Histopathological image, cerebellum, 
Lamb. No. 3. There is disorganization and atrophy of cerebellar folia. External granular 
layer is irregular and forms scattered cellular niches within the molecular layer (arrow). 
Purkinje cells are distributed throughout all the gray matter. There is no discernible inner 
granular layer. White matter area shows rarefaction and spongiosis (hypomyelination; 
asterisk). Hematoxylin-eosin stain, bar = 200 µm. Fig 2B. Immunohistochemically-stained 
image, brain, Lamb No. 1. There is punctate, brownish, positive signal within neurons 
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Table 1. Presence of BVDV 2b in tissues from three lambs with central nervous 
system malformations. Results of RT-qPCR / sequencing at the 5´-UTR are shown 
for the five different tissues studied in each lamb. 






Brain pos / seq wpos / seq wpos / seq 
Thyroid wpos / seq neg / nd wpos / no seq 
Lung wpos / seq wpos / seq wpos / nd 
Oral mucosa wpos / no seq neg / nd wpos / nd 
Aural skin wpos / nd neg / nd neg /nd 
 
pos: Positive in RT-qPCR (Ct≤ 32) 
wpos: Weakly positive in RT-qPCR (Ct >32 & <45) 
neg: Negative in RT-qPCR (Ct≥45) 
 
seq: 5´-UTR could be sequenced as BVDV 2b 
no seq: 5´UTR could not be sequenced 
nd: Sequencing not done (i.e. negative result in pre-sequencing, classic RT-PCR)  
A
cc
ep
te
d 
A
rt
ic
le
tbed_13619_f1.tif
This	article	is	protected	by	copyright.	All	rights	reserved
A
cc
ep
te
d 
A
rt
ic
le
tbed_13619_f2.tif
This	article	is	protected	by	copyright.	All	rights	reserved
A
cc
ep
te
d 
A
rt
ic
le
